Regulatory agilities impacting review timelines for Pfizer/BioNTech’s BNT162b2 mRNA COVID-19 vaccine: a retrospective study

por Patel, Prisha, Macdonald, Judith C., Boobalan, Jayanthi, Marsden, Matthew, Rizzi, Ruben, Zenon, Marianne, Ren, Jinma, Chu, Haitao, Cappelleri, Joseph C., Roychoudhury, Satrajit, O’Brien, Julie, Izaki-Lee, Konoha, Boyce, Donna
Publicado 2023